These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17972525)

  • 41. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas.
    Chang DT; Schellenberg D; Shen J; Kim J; Goodman KA; Fisher GA; Ford JM; Desser T; Quon A; Koong AC
    Cancer; 2009 Feb; 115(3):665-72. PubMed ID: 19117351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
    Jeremić B; Milicić B
    Cancer; 2008 Feb; 112(4):876-84. PubMed ID: 18172901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
    Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
    Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
    Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.
    Nguyen NP; Garland L; Welsh J; Hamilton R; Cohen D; Vinh-Hung V
    Cancer Treat Rev; 2008 Dec; 34(8):719-27. PubMed ID: 18657910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereotactic body radiotherapy in early stage non-small cell lung cancer: first experience from an Indian Centre.
    Kundu S; Mathew A; Munshi A; Prabhash K; Pramesh CS; Agarwal JP
    Indian J Cancer; 2013; 50(3):227-32. PubMed ID: 24061463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase I study of individualized stereotactic body radiotherapy of liver metastases.
    Lee MT; Kim JJ; Dinniwell R; Brierley J; Lockwood G; Wong R; Cummings B; Ringash J; Tse RV; Knox JJ; Dawson LA
    J Clin Oncol; 2009 Apr; 27(10):1585-91. PubMed ID: 19255313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II study on stereotactic body radiotherapy of colorectal metastases.
    Hoyer M; Roed H; Traberg Hansen A; Ohlhuis L; Petersen J; Nellemann H; Kiil Berthelsen A; Grau C; Aage Engelholm S; Von der Maase H
    Acta Oncol; 2006; 45(7):823-30. PubMed ID: 16982546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy.
    Milano MT; Chen Y; Katz AW; Philip A; Schell MC; Okunieff P
    Radiother Oncol; 2009 Jun; 91(3):301-6. PubMed ID: 19329210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stereotactic radiosurgery for the treatment of lung neoplasm: initial experience.
    Pennathur A; Luketich JD; Burton S; Abbas G; Heron DE; Fernando HC; Gooding WE; Ozhasoglu C; Ireland J; Landreneau RJ; Christie NA
    Ann Thorac Surg; 2007 May; 83(5):1820-4; discussion 1824-5. PubMed ID: 17462406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
    Svedman C; Sandström P; Pisa P; Blomgren H; Lax I; Kälkner KM; Nilsson S; Wersäll P
    Acta Oncol; 2006; 45(7):870-5. PubMed ID: 16982552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
    Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy.
    Nguyen QN; Shiu AS; Rhines LD; Wang H; Allen PK; Wang XS; Chang EL
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1185-92. PubMed ID: 19632064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors.
    Nuyttens JJ; van der Voort van Zyp NC; Praag J; Aluwini S; van Klaveren RJ; Verhoef C; Pattynama PM; Hoogeman MS
    Radiother Oncol; 2012 Mar; 102(3):383-7. PubMed ID: 22265734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
    McCammon R; Schefter TE; Gaspar LE; Zaemisch R; Gravdahl D; Kavanagh B
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):112-8. PubMed ID: 18786780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereotactic radiosurgery for early stage non-small cell lung cancer: rationale, patient selection, results, and complications.
    Christie NA; Pennathur A; Burton SA; Luketich JD
    Semin Thorac Cardiovasc Surg; 2008; 20(4):290-7. PubMed ID: 19251167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
    Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
    Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stereotactic radiotherapy for stage I lung cancer: current results and new developments.
    Senan S; Lagerwaard F
    Cancer Radiother; 2010 Apr; 14(2):115-8. PubMed ID: 20189429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.